➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Baxter
Dow
Johnson and Johnson
Mallinckrodt

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

Bethanechol chloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for bethanechol chloride and what is the scope of patent protection?

Bethanechol chloride is the generic ingredient in four branded drugs marketed by Odyssey Pharms, Able, Actavis Elizabeth, Amneal Pharm, Ascot, Discovery Therap, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, Wockhardt, Chartwell Rx, and Glenwood, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for bethanechol chloride. Ten suppliers are listed for this compound.

Recent Clinical Trials for bethanechol chloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rajavithi HospitalPhase 4

See all bethanechol chloride clinical trials

Pharmacology for bethanechol chloride
Medical Subject Heading (MeSH) Categories for bethanechol chloride

US Patents and Regulatory Information for bethanechol chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040897-001 Apr 22, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 084402-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Wockhardt BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040518-001 Sep 29, 2003 AA RX No No   Start Trial   Start Trial   Start Trial
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 006536-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Discovery Therap BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040728-002 Oct 26, 2007 AA RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharm BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040855-004 Nov 21, 2007 AA RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKesson
Harvard Business School
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.